首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2017年 10期小儿肝胆胰疾病 => 综述 =>不同评分系统在原发性肝癌肝动脉化..
不同评分系统在原发性肝癌肝动脉化疗栓塞术预后判断中的应用
Application of different scoring systems in evaluating prognosis after transarterial chemoembolization for primary liver cancer
文章发布日期:2017年09月07日  来源:  作者:汪晓芳, 朱丽影, 卢宝玲, 等  点击次数:1198次  下载次数:273次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:原发性肝癌治疗指南众多,其中巴塞罗那肝癌分期(BCLC)是国际上通常采用的肝癌治疗参考标准,然而只有B期符合肝动脉化疗栓塞术(TACE)的指征,限制了其临床应用。因此,近年来相继提出了评估原发性肝癌TACE治疗预后的评分系统,为原发性肝癌治疗提供重要参考。介绍了有关TACE治疗预后评分系统的应用现状,指出各评分系统的优缺点及评估效能,为肝癌治疗提供理论依据。
【Abstract】:There are many treatment guidelines for primary liver cancer, among which Barcelona Clinic Liver Cancer (BCLC) is commonly used as the reference for the treatment of liver cancer in the world; however, only BCLC stage B patients meet the indication for transarterial chemoembolization (TACE), which limits the clinical application of TACE. Therefore, several scoring systems for evaluating prognosis after TACE have been developed in recent years and provide an important reference for the treatment of primary liver cancer. This article introduces the application of scoring systems for evaluating prognosis after TACE and points out their advantages/disadvantages and performance, in order to provide a theoretical basis for the treatment of liver cancer.
【关键字】:肝肿瘤; 化学栓塞, 治疗性; 预后; 综述
【Key words】:liver neoplasms; chemoembolization, therapeutic; prognosis; review
【引证本文】:汪晓芳, 朱丽影, 卢宝玲, 等. 不同评分系统在原发性肝癌肝动脉化疗栓塞术预后判断中的应用[J]. 临床肝胆病杂志, 2017, 33(10): 2016-2020.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号